A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Clinical trial NCT05923866 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05923866
Sponsor: Ono Pharmaceutical Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple System Atrophy (MSA)

Start date: 2023-09-22
Primary completion: 2025-09-15
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.